Peptide

Abaloparatide (Tymlos)

FDA-approved product existsRecovery & tissue repair
Not yet scored

BioHarmony verdict

Awaiting review

No BioHarmony report yet. It is queued for review; until then, rely on the status and sources below.

What is Abaloparatide (Tymlos)?

FDA-approved abaloparatide is marketed as Tymlos for specified women and men with osteoporosis at high fracture risk or who have failed or cannot tolerate other therapy.

Dosing as published

Approved labelTYMLOS prescribing information for approved osteoporosis indications
PopulationWomen and men covered by the approved TYMLOS indications
Dose80 mcg
RouteSubcutaneous injection into the periumbilical abdomen
FrequencyOnce daily at approximately the same time each day
DurationThe label states that safety and effectiveness beyond 2 years have not been evaluated and use beyond 2 years during a lifetime is not recommended
PreparationReady-to-use 3120 mcg/1.56 mL solution in a prefilled pen delivering thirty 80 mcg doses; no reconstitution.
Source: Dosage and Administration sections 2.1-2.3; Dosage Forms and Strengths section 3

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved
Last checked2026-07-13
Next review2026-10-11

Primary sources

  1. 7.5/10BPC-157Strong recommendRecoveryNot FDA approvedBPC-157 is a 15-amino-acid gastric peptide fragment with consistent preclinical repair data, including a 2025 sports-medicine systematic review of 36 studies with 35…
  2. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  3. 7.4/10GHK-Cu (Copper Peptide)Strong recommendRecoveryNot FDA approvedGHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
  4. 7.3/10Thymosin Alpha-1Strong recommendRecoveryNot FDA approvedFDA identifies immunogenicity and peptide-impurity concerns for compounded thymosin alpha-1 and says available safety information is inadequate.

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.